• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型钌配合物K2[Ru(dmgly)Cl4].2H2O对C6星形细胞瘤细胞系有毒性,但对原代大鼠星形胶质细胞无毒。

Novel ruthenium complex K2[Ru(dmgly)Cl4].2H2O is toxic to C6 astrocytoma cell line, but not to primary rat astrocytes.

作者信息

Djinović Vesna, Momcilović Miljana, Grgurić-Sipka Sanja, Trajković Vladimir, Mostarica Stojković Marija, Miljković Djordje, Sabo Tibor

机构信息

Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia and Montenegro.

出版信息

J Inorg Biochem. 2004 Dec;98(12):2168-73. doi: 10.1016/j.jinorgbio.2004.10.007.

DOI:10.1016/j.jinorgbio.2004.10.007
PMID:15541507
Abstract

A novel class of ruthenium (III) complexes of formulas K[Ru(sar)2Cl2].12H2O and K2[Ru(dmgly)Cl4].2H2O, containing bidentate chelates N-methylglycine (sarcosine, sar) or N,N-dimethylglycine (dmgly) and additional chloro ligands were synthesized. The complexes have been obtained by direct reaction of ruthenium(III) chloride with corresponding bidentate ligand followed by addition of base (KOH). These new complexes were characterized by elemental analysis, IR and electronic absorption spectroscopy. As astrocytomas, the most common of all brain tumors, are still very difficult to treat, we examined the influence of newly synthesized ruthenium-based complexes, as well as the earlier synthesized analogue platinum(IV) complexes [Pt(dmgly)2Cl2], [Pt(sar)2Br2] and [Pt(dmgly)2Br2], on rat astrocytoma C6 cells in vitro. Among these complexes only K2[Ru(dmgly)Cl4].2H2O and [Pt(dmgly)2Br2] markedly inhibited the viability of non-confluent C6 cells. Furthermore, only complex K2[Ru(dmgly)Cl4].2H2O was able to reduce viability in confluent C6 cultures. Importantly, this complex was not toxic to primary rat astrocytes or macrophages. Having in mind that appropriate chemotherapy should be effective against tumor cells without harming normal tissues, complex K2[Ru(dmgly)Cl4].2H2O could be a promising agent for developing therapeutics against astrocytomas.

摘要

合成了一类新型的化学式为K[Ru(sar)₂Cl₂]·12H₂O和K₂[Ru(dmgly)Cl₄]·2H₂O的钌(III)配合物,其含有双齿螯合物N-甲基甘氨酸(肌氨酸,sar)或N,N-二甲基甘氨酸(dmgly)以及额外的氯配体。这些配合物是通过氯化钌(III)与相应的双齿配体直接反应,随后加入碱(KOH)得到的。通过元素分析、红外光谱和电子吸收光谱对这些新配合物进行了表征。由于星形细胞瘤是所有脑肿瘤中最常见的,但仍然很难治疗,我们研究了新合成的钌基配合物以及早期合成的类似物铂(IV)配合物[Pt(dmgly)₂Cl₂]、[Pt(sar)₂Br₂]和[Pt(dmgly)₂Br₂]对大鼠星形细胞瘤C6细胞的体外影响。在这些配合物中,只有K₂[Ru(dmgly)Cl₄]·2H₂O和[Pt(dmgly)₂Br₂]显著抑制了未汇合的C6细胞的活力。此外,只有配合物K₂[Ru(dmgly)Cl₄]·2H₂O能够降低汇合的C6培养物中的活力。重要的是,这种配合物对原代大鼠星形胶质细胞或巨噬细胞无毒。考虑到合适的化疗应该对肿瘤细胞有效而不损害正常组织,配合物K₂[Ru(dmgly)Cl₄]·2H₂O可能是开发抗星形细胞瘤治疗药物的有前景的试剂。

相似文献

1
Novel ruthenium complex K2[Ru(dmgly)Cl4].2H2O is toxic to C6 astrocytoma cell line, but not to primary rat astrocytes.新型钌配合物K2[Ru(dmgly)Cl4].2H2O对C6星形细胞瘤细胞系有毒性,但对原代大鼠星形胶质细胞无毒。
J Inorg Biochem. 2004 Dec;98(12):2168-73. doi: 10.1016/j.jinorgbio.2004.10.007.
2
[Pt(HPxSC)Cl(3)], a novel platinum(IV) compound with anticancer properties.[Pt(HPxSC)Cl(3)],一种具有抗癌特性的新型铂(IV)化合物。
Eur J Pharmacol. 2005 Jul 4;517(1-2):28-34. doi: 10.1016/j.ejphar.2005.05.038.
3
New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.新型细胞毒性水溶性双(2-苯基偶氮吡啶)钌(II)配合物
J Med Chem. 2003 Apr 24;46(9):1743-50. doi: 10.1021/jm021110e.
4
Ru(III)-based compounds with sulfur donor ligands: synthesis, characterization, electrochemical behaviour and anticancer activity.含硫供体配体的钌(III)化合物:合成、表征、电化学行为及抗癌活性
Dalton Trans. 2008 Dec 21(47):6699-708. doi: 10.1039/b806341a. Epub 2008 Oct 14.
5
Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes.一些单核钌(II)配合物的合成、抗肿瘤和细胞毒性活性。
J Enzyme Inhib Med Chem. 2010 Aug;25(4):513-9. doi: 10.3109/14756360903357577.
6
Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-.抗肿瘤配合物反式-[Ru(III)Cl4(吲唑)2]-的水合产物的合成与反应活性
Inorg Chem. 2008 Jul 21;47(14):6513-23. doi: 10.1021/ic800506g. Epub 2008 Jun 14.
7
Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.以抗癌药物为配体的钌(II)配合物的研究。金属基光疗剂的设计。
Inorg Chem. 2003 Dec 1;42(24):8038-52. doi: 10.1021/ic0349095.
8
Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.强效抗肿瘤配合物反式-[Ru(III)Cl4(吲唑)2]与一种与DNA相关的核碱基及硫醚的反应:对生物活性的深入了解
Inorg Chem. 2005 Jan 10;44(1):122-32. doi: 10.1021/ic048967h.
9
Hetero-multinuclear ruthenium(III)/platinum(II) complexes that potentially exhibit both antimetastatic and antineoplastic properties.具有潜在的抗转移和抗肿瘤活性的杂多核钌(III)/铂(II)配合物。
Inorg Chem. 2012 Dec 3;51(23):12917-24. doi: 10.1021/ic301981s. Epub 2012 Nov 14.
10
Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.与4-苯胺基喹唑啉衍生物配位的新型钌配合物:合成、表征及生物活性初步评价
Eur J Med Chem. 2014 Apr 22;77:110-20. doi: 10.1016/j.ejmech.2014.02.062. Epub 2014 Mar 1.

引用本文的文献

1
Pharmacotherapy for adults with tumors of the central nervous system.成人中枢神经系统肿瘤的药物治疗
Pharmacol Ther. 2009 Mar;121(3):253-64. doi: 10.1016/j.pharmthera.2008.11.003. Epub 2008 Nov 27.